-
A molecular clone of HTLV-III with biological activity.
Nature. 1985 Jul 18-24;316(6025):262-5
PMID: 2410792
-
Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein.
J Virol. 1992 Sep;66(9):5635-41
PMID: 1380099
-
Induction of anti-HIV neutralizing antibodies by synthetic peptides.
EMBO J. 1986 Nov;5(11):3065-71
PMID: 3466790
-
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.
Proc Natl Acad Sci U S A. 1986 Dec;83(24):9709-13
PMID: 2432599
-
Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.
Science. 1988 Feb 26;239(4843):1021-3
PMID: 2830667
-
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
Proc Natl Acad Sci U S A. 1988 Mar;85(6):1932-6
PMID: 2450351
-
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.
Proc Natl Acad Sci U S A. 1988 May;85(9):3198-202
PMID: 2452447
-
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
J Virol. 1988 Jun;62(6):2107-14
PMID: 2452899
-
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4478-82
PMID: 2454471
-
Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.
Cell. 1988 Jul 1;54(1):57-63
PMID: 2838179
-
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide.
Virology. 1988 Jul;165(1):209-15
PMID: 2838959
-
Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120.
J Virol. 1989 Sep;63(9):3595-600
PMID: 2547987
-
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72
PMID: 2771954
-
Characterization of HIV-1 neutralization escape mutants.
AIDS. 1989 Dec;3(12):777-84
PMID: 2483618
-
Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.
AIDS. 1990 Feb;4(2):107-12
PMID: 2328092
-
Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
AIDS. 1990 Apr;4(4):297-305
PMID: 2190604
-
Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.
J Immunol. 1990 Jun 15;144(12):4641-7
PMID: 1693639
-
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.
J Virol. 1990 Jul;64(7):3240-8
PMID: 2352323
-
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.
Science. 1990 Dec 14;250(4987):1590-3
PMID: 1703322
-
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
J Immunol. 1991 Jun 15;146(12):4325-32
PMID: 1710248
-
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody.
J Virol. 1991 Nov;65(11):6188-93
PMID: 1717717
-
Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8949-52
PMID: 1717992
-
Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.
Science. 1991 Oct 4;254(5028):105-8
PMID: 1718036
-
Antigenic diversity thresholds and the development of AIDS.
Science. 1991 Nov 15;254(5034):963-9
PMID: 1683006
-
Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.
J Virol. 1992 Dec;66(12):7538-42
PMID: 1433529
-
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.
J Virol. 1993 Feb;67(2):863-75
PMID: 7678308
-
Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1.
Intervirology. 1992;34(2):86-93
PMID: 1284059
-
HIV-1 neutralization directed to epitopes other than linear V3 determinants.
AIDS. 1991;5 Suppl 2:S135-43
PMID: 1726953
-
Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.
J Virol. 1993 Jun;67(6):3674-9
PMID: 8497077
-
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
J Virol. 1993 Jul;67(7):3978-88
PMID: 7685405
-
Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop.
J Virol. 1993 Aug;67(8):4785-96
PMID: 7687303
-
An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
Virology. 1993 Sep;196(1):332-7
PMID: 8356803
-
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
J Virol. 1993 Oct;67(10):6136-51
PMID: 7690418
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.
J Virol. 1993 Nov;67(11):6642-7
PMID: 7692082
-
Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.
J Virol. 1993 Dec;67(12):7493-500
PMID: 7693973
-
Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.
J Biol Chem. 1993 Dec 5;268(34):25894-901
PMID: 7503990
-
A rapid method for site-specific mutagenesis using larger plasmids as templates.
Biotechniques. 1993 Oct;15(4):700-4
PMID: 8251172
-
Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change.
J Virol. 1994 Feb;68(2):674-80
PMID: 7507184
-
Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop.
J Virol. 1994 Feb;68(2):974-8
PMID: 7507188
-
Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
J Virol. 1994 Apr;68(4):2503-12
PMID: 8139032
-
Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1.
J Virol. 1994 Nov;68(11):6836-47
PMID: 7933065
-
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.
J Virol. 1994 Dec;68(12):8312-20
PMID: 7525987
-
Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions.
J Virol. 1995 Mar;69(3):1860-7
PMID: 7853527
-
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
J Virol. 1995 Sep;69(9):5723-33
PMID: 7543586
-
Antigenic analysis of HIV type 1 external envelope (Env) glycoprotein C2 region: implication for the structure of Env.
AIDS Res Hum Retroviruses. 1995 Oct;11(10):1177-86
PMID: 8573373
-
Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.
J Virol. 1996 Mar;70(3):1863-72
PMID: 8627711
-
Using PCR for rapid site-specific mutagenesis in large plasmids.
Methods Mol Biol. 1996;57:217-27
PMID: 8850008
-
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.
J Virol. 1992 Feb;66(2):848-56
PMID: 1370558
-
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
J Virol. 1992 Mar;66(3):1823-31
PMID: 1637373
-
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.
Science. 1992 Jun 19;256(5064):1687-90
PMID: 1609280
-
In vitro generation of an HTLV-III variant by neutralizing antibody.
J Immunol. 1986 Nov 15;137(10):3306-9
PMID: 3639908